OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents
Amelia Licari, Riccardo Castagnoli, Alessia Marseglia, et al.
Pediatric Drugs (2020) Vol. 22, Iss. 3, pp. 295-310
Closed Access | Times Cited: 74

Showing 26-50 of 74 citing articles:

Time effect of dupilumab to treat severe uncontrolled asthma in adolescents
Cristiana Indolfi, Giulio Dinardo, Angela Klain, et al.
Allergologia et Immunopathologia (2023) Vol. 51, Iss. 5, pp. 12-18
Open Access | Times Cited: 7

Novel therapeutic approaches targeting endotypes of severe airway disease
Maria De Filippo, Martina Votto, Amelia Licari, et al.
Expert Review of Respiratory Medicine (2021) Vol. 15, Iss. 10, pp. 1303-1316
Closed Access | Times Cited: 17

Combining Anti-IgE Monoclonal Antibodies and Oral Immunotherapy for the Treatment of Food Allergy
Laurent Guilleminault, Marine Michelet, Laurent L. Reber
Clinical Reviews in Allergy & Immunology (2021) Vol. 62, Iss. 1, pp. 216-231
Closed Access | Times Cited: 17

Barrier Impairment and Type 2 Inflammation in Allergic Diseases: The Pediatric Perspective
Michele Ghezzi, Elena Pozzi, Luisa Abbattista, et al.
Children (2021) Vol. 8, Iss. 12, pp. 1165-1165
Open Access | Times Cited: 17

Severe pediatric asthma therapy: Dupilumab
Giuliana Ferrante, Laura Tenero, Michele Piazza, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 12

An Updated Reappraisal of Dupilumab in Children and Adolescents with Severe Asthma
Gian Luigi Marseglia, Amelia Licari, Maria Angela Tosca, et al.
Children (2024) Vol. 11, Iss. 7, pp. 843-843
Open Access | Times Cited: 2

Difficult and Severe Asthma in Children
Federica Porcaro, Nicola Ullmann, Annalisa Allegorico, et al.
Children (2020) Vol. 7, Iss. 12, pp. 286-286
Open Access | Times Cited: 17

Eosinophilic Gastrointestinal Diseases in Inborn Errors of Immunity
Martina Votto, Matteo Naso, Ilaria Brambilla, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 2, pp. 514-514
Open Access | Times Cited: 6

Dupilumab as a novel steroid-sparing treatment for hypereosinophilic syndrome
Xiaoman Du, Yudi Chen, Jianmin Chang, et al.
JAAD Case Reports (2022) Vol. 29, pp. 106-109
Open Access | Times Cited: 9

The changes of IgE levels in type 2 inflammatory diseases after treatment of dupilumab: a systematic review and meta-analysis
Boyang Zhou, Jialin Dong, Surong Liang, et al.
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 10, pp. 1233-1242
Open Access | Times Cited: 9

The Saudi initiative for asthma – 2024 update: Guidelines for the diagnosis and management of asthma in adults and children
Mohamed Al-Moamary, Sami Alhaider, Riyad Al‐Lehebi, et al.
Annals of Thoracic Medicine (2023)
Open Access | Times Cited: 5

OR2AT4 and OR1A2 counterregulate molecular pathophysiological processes of steroid-resistant inflammatory lung diseases in human alveolar macrophages
Daniel Weidinger, Kaschin Jamal Jameel, Desiree Alisch, et al.
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 8

An update on biological therapies for pediatric allergic diseases
Riccardo Castagnoli, Maria De Filippo, Martina Votto, et al.
Minerva Pediatrica (2020) Vol. 72, Iss. 5
Closed Access | Times Cited: 11

Pediatric chronic spontaneous urticaria: a brief clinician’s guide
Martina Votto, Giovanna Achilli, Maria De Filippo, et al.
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 9, pp. 889-899
Closed Access | Times Cited: 6

Treatment‐emergent adverse events in dupilumab‐treated patients with allergic diseases: A meta‐analysis
Xiaohong Chen, Menghui Liu, Shuo Wu, et al.
Allergy (2020) Vol. 76, Iss. 2, pp. 593-596
Closed Access | Times Cited: 9

Type‐2 inflammatory mediators as targets for precision medicine in children
Riccardo Castagnoli, Amelia Licari, Sara Manti, et al.
Pediatric Allergy and Immunology (2020) Vol. 31, Iss. S26, pp. 17-19
Open Access | Times Cited: 9

Shedding light on key pharmacological knowledge and strategies for pediatric atopic dermatitis
Ariana Moreno, Yael Renert‐Yuval, Emma Guttman‐Yassky
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 2, pp. 119-131
Open Access | Times Cited: 3

IgE and anaphylaxis specific to the carbohydrate alpha-gal depend on IL-4
Miriam Hils, Nils Hoffard, Caterina Iuliano, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 4, pp. 1050-1062.e6
Open Access | Times Cited: 3

Dupilumab for chronic eosinophilic pneumonia
Christopher Fowler, Wynton Hoover
Pediatric Pulmonology (2020) Vol. 55, Iss. 12, pp. 3229-3230
Open Access | Times Cited: 8

Short communication: Comments on hair disorders associated with dupilumab based on VigiBase
Sunny Park, So Hyang Park, Young Hoon Joo, et al.
PLoS ONE (2022) Vol. 17, Iss. 7, pp. e0270906-e0270906
Open Access | Times Cited: 5

Pediatric Unified Airway
Carly Mulinda, Nathan Yang, David A. Gudis
Otolaryngologic Clinics of North America (2022) Vol. 56, Iss. 1, pp. 137-146
Closed Access | Times Cited: 5

Biologic Therapy of Moderate and Severe Forms of Atopic Dermatitis in Children
Nikolay N. Murashkin, Leyla S. Namazova-Baranova, Leonid A. Opryatin, et al.
Вопросы современной педиатрии (2020) Vol. 19, Iss. 6, pp. 432-443
Open Access | Times Cited: 6

Rapid response to dupilumab treatment in children with moderate‐to‐severe atopic dermatitis: A case series
Martina Votto, Francesco Delle Cave, Maria De Filippo, et al.
Pediatric Allergy and Immunology (2022) Vol. 33, Iss. S27, pp. 31-33
Open Access | Times Cited: 4

Do not forget asthma comorbidities in pediatric severe asthma!
Lucia Ronco, Anna Folino, Manuela Goia, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 4

Il dupilumab nell’esofagite eosinofila: una nuova frontiera?
Martina Mainetti, Angela Troisi, Giuliana Turlà, et al.
Medico e Bambino (2022) Vol. 41, Iss. 1, pp. 583-587
Closed Access | Times Cited: 4

Scroll to top